# Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open‐Label Transition From Reference Infliximab to Biosimilar Infliximab

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/subjective-complaints-as-the-main-reason-for-biosimilar-discontinuation-after/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Lieke Tweehuysen,Bart J. F. van den Bemt,Iris L. van Ingen,Alphons J.L. de Jong,W.H. van der Laan,F.H.J. van den Hoogen,Alfons A den Broeder |
| Citations | 164 |
| DOI | 10.1002/art.40324 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2766388803 |
| PMID | 29045077 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Bart J. F. van den Bemt](https://scholariq.org/researchers/bart-j-f-van-den-bemt/)

## Paper journal

- [Arthritis & Rheumatology](https://scholariq.org/journals/arthritis-and-rheumatology/)

## Paper primary topic

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Paper topics

- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.